PH25977A - Medicated cleansing pads - Google Patents
Medicated cleansing pads Download PDFInfo
- Publication number
- PH25977A PH25977A PH38120A PH38120A PH25977A PH 25977 A PH25977 A PH 25977A PH 38120 A PH38120 A PH 38120A PH 38120 A PH38120 A PH 38120A PH 25977 A PH25977 A PH 25977A
- Authority
- PH
- Philippines
- Prior art keywords
- medicated
- pad according
- pad
- weight
- styrene
- Prior art date
Links
- 239000000178 monomer Substances 0.000 claims abstract description 31
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000000203 mixture Substances 0.000 claims abstract description 26
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 24
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 24
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 10
- 229920001577 copolymer Polymers 0.000 claims abstract description 9
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 8
- 229920003002 synthetic resin Polymers 0.000 claims abstract description 4
- 239000007787 solid Substances 0.000 claims abstract description 3
- 239000002952 polymeric resin Substances 0.000 claims abstract 3
- 229920005989 resin Polymers 0.000 claims description 24
- 239000011347 resin Substances 0.000 claims description 24
- 206010000496 acne Diseases 0.000 claims description 18
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 229940119073 medicated pad Drugs 0.000 claims description 12
- 229940104261 taurate Drugs 0.000 claims description 7
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 5
- 229920000297 Rayon Polymers 0.000 claims description 5
- 239000002964 rayon Substances 0.000 claims description 5
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 claims description 3
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 241000206607 Porphyra umbilicalis Species 0.000 claims 1
- 150000003440 styrenes Chemical class 0.000 abstract description 3
- 239000000835 fiber Substances 0.000 description 37
- 239000000306 component Substances 0.000 description 20
- 230000003255 anti-acne Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 239000004744 fabric Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 238000000151 deposition Methods 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- 239000002174 Styrene-butadiene Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 239000011115 styrene butadiene Substances 0.000 description 4
- 229920003048 styrene butadiene rubber Polymers 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002361 compost Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 229920002972 Acrylic fiber Polymers 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 241000208680 Hamamelis mollis Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 230000003113 alkalizing effect Effects 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- -1 salicylic actd Chemical compound 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 229940118846 witch hazel Drugs 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NVZWEEGUWXZOKI-UHFFFAOYSA-N 1-ethenyl-2-methylbenzene Chemical compound CC1=CC=CC=C1C=C NVZWEEGUWXZOKI-UHFFFAOYSA-N 0.000 description 1
- PETPJXCKASLNTF-UHFFFAOYSA-N 2-methylbuta-1,3-diene;3-methylidenepent-1-ene Chemical compound CC(=C)C=C.CCC(=C)C=C PETPJXCKASLNTF-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- 229920013659 Acele Polymers 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 244000198134 Agave sisalana Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- 102100030796 E3 ubiquitin-protein ligase rififylin Human genes 0.000 description 1
- 101710128004 E3 ubiquitin-protein ligase rififylin Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 101000831887 Homo sapiens STE20-related kinase adapter protein alpha Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 229920002821 Modacrylic Polymers 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 102100024171 STE20-related kinase adapter protein alpha Human genes 0.000 description 1
- 235000014328 Schoenoplectus acutus var occidentalis Nutrition 0.000 description 1
- 244000136421 Scirpus acutus Species 0.000 description 1
- 235000014326 Scirpus californicus Nutrition 0.000 description 1
- 235000017913 Scirpus lacustris Nutrition 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- WTHXTWHYLIZJBH-UHFFFAOYSA-N acetic acid;azane Chemical compound N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O WTHXTWHYLIZJBH-UHFFFAOYSA-N 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- MPMBRWOOISTHJV-UHFFFAOYSA-N but-1-enylbenzene Chemical compound CCC=CC1=CC=CC=C1 MPMBRWOOISTHJV-UHFFFAOYSA-N 0.000 description 1
- QNRMTGGDHLBXQZ-UHFFFAOYSA-N buta-1,2-diene Chemical compound CC=C=C QNRMTGGDHLBXQZ-UHFFFAOYSA-N 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 238000009960 carding Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002995 comedolytic effect Effects 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000037416 cystogenesis Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- KETWBQOXTBGBBN-UHFFFAOYSA-N hex-1-enylbenzene Chemical compound CCCCC=CC1=CC=CC=C1 KETWBQOXTBGBBN-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N retinoic acid group Chemical class C\C(=C/C(=O)O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- IZWPGJFSBABFGL-GMFCBQQYSA-M sodium;2-[methyl-[(z)-octadec-9-enoyl]amino]ethanesulfonate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CCS([O-])(=O)=O IZWPGJFSBABFGL-GMFCBQQYSA-M 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/48—Surfactants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Production Of Multi-Layered Print Wiring Board (AREA)
- External Artificial Organs (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/151,338 US4891228A (en) | 1988-02-02 | 1988-02-02 | Medicated cleansing pads |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH25977A true PH25977A (en) | 1992-01-13 |
Family
ID=22538308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH38120A PH25977A (en) | 1988-02-02 | 1989-01-30 | Medicated cleansing pads |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4891228A (ko) |
| EP (1) | EP0327326B1 (ko) |
| JP (1) | JP2885815B2 (ko) |
| KR (1) | KR0136273B1 (ko) |
| AT (1) | ATE89998T1 (ko) |
| AU (1) | AU613295B2 (ko) |
| CA (1) | CA1337897C (ko) |
| DE (1) | DE68906804T2 (ko) |
| DK (1) | DK47789A (ko) |
| ES (1) | ES2040994T3 (ko) |
| GR (1) | GR3008079T3 (ko) |
| HK (1) | HK1006146A1 (ko) |
| IE (1) | IE62870B1 (ko) |
| MX (1) | MX165382B (ko) |
| MY (1) | MY105806A (ko) |
| NZ (1) | NZ227823A (ko) |
| PH (1) | PH25977A (ko) |
Families Citing this family (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4891227A (en) * | 1988-02-02 | 1990-01-02 | Richardson-Vicks Inc. | Medicated cleansing pads |
| ATE198702T1 (de) * | 1991-11-25 | 2001-02-15 | Richardson Vicks Inc | Verwendungvon salicylsäure zur kontrolle der hautatrophie |
| EP0614353A1 (en) * | 1991-11-25 | 1994-09-14 | Richardson-Vicks, Inc. | Compositions for regulating skin wrinkles and/or skin atrophy |
| US5780459A (en) * | 1991-11-25 | 1998-07-14 | The Procter & Gamble Company | Compositions for regulating skin wrinkles and or skin atrophy |
| US5466456A (en) * | 1991-11-27 | 1995-11-14 | Glover; Morris S. | Facial cleanser |
| JPH07506367A (ja) * | 1992-05-05 | 1995-07-13 | ザ、プロクター、エンド、ギャンブル、カンパニー | アクネ治療組成物 |
| AU4682793A (en) * | 1992-07-27 | 1994-02-14 | Procter & Gamble Company, The | Laminated dual textured treatment pads |
| CN1123523A (zh) * | 1993-04-20 | 1996-05-29 | 普罗克特和甘保尔公司 | 用橙皮甙元控制皮脂和治疗痤疮的方法 |
| EP0703775A4 (en) * | 1993-06-01 | 1997-02-26 | Dermatology Home Prod Inc | SKIN TREATMENT METHOD USING A COMPOSITION AND PAD |
| US5505948A (en) * | 1993-06-01 | 1996-04-09 | Dermatology Home Products, Inc. | Home skin peel composition for producing healthy and attractive skin |
| US6103644A (en) | 1993-12-22 | 2000-08-15 | Nordico Marketing Development, Inc. | Impregnated matrix and method for making same |
| US5549888A (en) * | 1994-01-31 | 1996-08-27 | Procter & Gamble | Aqueous topical anti-acne compositions of low pH |
| US5538732A (en) * | 1994-04-12 | 1996-07-23 | Creative Products Resource, Inc. | Medicated applicator sheet for topical drug delivery |
| US5558873A (en) * | 1994-06-21 | 1996-09-24 | Kimberly-Clark Corporation | Soft tissue containing glycerin and quaternary ammonium compounds |
| US5976521A (en) * | 1994-08-09 | 1999-11-02 | The Procter & Gamble Company | Anti-acne cosmetic compositions |
| US5601871A (en) * | 1995-02-06 | 1997-02-11 | Krzysik; Duane G. | Soft treated uncreped throughdried tissue |
| US5665426A (en) * | 1995-02-06 | 1997-09-09 | Kimberly-Clark Corporation | Soft treated tissue |
| AU721214B2 (en) | 1996-02-08 | 2000-06-29 | Albert M. Kligman | Composition and method for effecting superficial chemical skin peels |
| US5741497A (en) * | 1996-06-25 | 1998-04-21 | Elizabeth Arden Company | Skin treatment with salicylic acid esters |
| US5891451A (en) * | 1996-06-25 | 1999-04-06 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin treatment with salicylic acid esters |
| US6063397A (en) * | 1996-10-25 | 2000-05-16 | The Procter & Gamble Company | Disposable cleansing products for hair and skin |
| US6338855B1 (en) | 1996-10-25 | 2002-01-15 | The Procter & Gamble Company | Cleansing articles for skin and/or hair which also deposit skin care actives |
| US5972361A (en) * | 1996-10-25 | 1999-10-26 | The Procter & Gamble Company | Cleansing products |
| US5773015A (en) * | 1996-11-27 | 1998-06-30 | Elizabeth Arden Co., Division Of Conopco, Inc. | Method for controlling skin oils and grease |
| US5728732A (en) * | 1996-11-27 | 1998-03-17 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin treatment with salicylic acid esters and retinoids |
| US5885697A (en) * | 1996-12-17 | 1999-03-23 | Kimberly-Clark Worldwide, Inc. | Soft treated tissue |
| TW552140B (en) * | 1997-04-09 | 2003-09-11 | Kao Corp | Skin cleansing sheet |
| US5951991A (en) * | 1997-05-22 | 1999-09-14 | The Procter & Gamble Company | Cleansing products with improved moisturization |
| US6132746A (en) * | 1997-05-22 | 2000-10-17 | The Procter & Gamble Company | Cleansing products with improved moisturization |
| US6280757B1 (en) * | 1997-05-22 | 2001-08-28 | The Procter & Gamble Company | Cleansing articles for skin or hair |
| US6183757B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing |
| US6183763B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved immediate germ reduction |
| US6190675B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria |
| US6284259B1 (en) | 1997-11-12 | 2001-09-04 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria |
| US5968539A (en) * | 1997-06-04 | 1999-10-19 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria |
| US6214363B1 (en) | 1997-11-12 | 2001-04-10 | The Procter & Gamble Company | Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria |
| US6197315B1 (en) | 1997-06-04 | 2001-03-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria |
| US6210695B1 (en) | 1997-06-04 | 2001-04-03 | The Procter & Gamble Company | Leave-on antimicrobial compositions |
| US6258368B1 (en) * | 1997-06-04 | 2001-07-10 | The Procter & Gamble Company | Antimicrobial wipes |
| US6190674B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Liquid antimicrobial cleansing compositions |
| US6287577B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria |
| BR9811758A (pt) | 1997-09-05 | 2000-08-29 | Procter & Gamble | Produto de limpeza e condicionamento para tratamento pessoal de utilização única, descartável e processos para manufaturar, para distribuir e para limpar e condicionar a pele com esse produto |
| DE69808790T3 (de) * | 1997-09-12 | 2009-07-16 | The Procter & Gamble Co., Cincinnati | Hautreinigungs- und konditionierungsartikel für haut und haar |
| US6287583B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Low-pH, acid-containing personal care compositions which exhibit reduced sting |
| FR2774287B1 (fr) * | 1998-01-30 | 2000-05-12 | Oreal | Patch nettoyant, revelateur de l'etat de la peau |
| US6962904B1 (en) * | 1998-03-13 | 2005-11-08 | Connective Tissue Imagineering | Elastin peptide analogs and uses thereof |
| US6809075B1 (en) | 2000-05-30 | 2004-10-26 | Connective Tissue Imagineering Llc | Elastin peptide analogs and uses of same incombination with skin enhancing agents |
| WO1999049833A1 (fr) * | 1998-03-30 | 1999-10-07 | Kao Corporation | Film couvrant pour la peau ou les cheveux |
| CA2332948A1 (en) * | 1998-04-24 | 1999-11-04 | The Procter & Gamble Company | Cleansing articles for skin and/or hair which also deposits skin care actives |
| US6106818A (en) * | 1998-04-27 | 2000-08-22 | Revlon Consumer Products Corporation | Method for removing dead surface cells, dirt, oil, and blackheads from the skin and related compositions and articles |
| US6777389B1 (en) | 1998-11-19 | 2004-08-17 | Connective Tissue Imagineering Llc | Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides |
| US6537933B1 (en) * | 1999-02-17 | 2003-03-25 | Yuzo Tsuchida | Silk cloths for protecting affected parts |
| US6488943B1 (en) | 1999-04-13 | 2002-12-03 | The Procter & Gamble Company | Antimicrobial wipes which provide improved immediate germ reduction |
| US6482423B1 (en) | 1999-04-13 | 2002-11-19 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram positive bacteria |
| US6413529B1 (en) | 1999-04-13 | 2002-07-02 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria |
| US6319510B1 (en) | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
| US6242491B1 (en) * | 1999-06-25 | 2001-06-05 | Rima Kaddurah-Daouk | Use of creatine or creatine compounds for skin preservation |
| US6296869B1 (en) | 1999-07-30 | 2001-10-02 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Adhesive cosmetic patch containing alpha or beta hydroxy acids |
| US6428798B1 (en) * | 1999-08-24 | 2002-08-06 | Lisa Bachrach | Blemish extraction means |
| US6355261B1 (en) | 1999-12-02 | 2002-03-12 | The C. P. Hall Company | Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
| KR100732110B1 (ko) * | 1999-12-30 | 2007-06-27 | 킴벌리-클라크 월드와이드, 인크. | 항균성 흡수용품, 및 그의 제조 및 사용 방법 |
| AU2001255487A1 (en) * | 2000-04-21 | 2001-11-07 | Nature's Cure | Salicylic acid acne spray formulations and methods for treating acne with same |
| US6794362B1 (en) | 2000-05-30 | 2004-09-21 | Connective Tissue Imagineering Llc | Asparagine containing elastin peptide analogs |
| US6696070B2 (en) * | 2000-09-08 | 2004-02-24 | Johnson & Johnson Consumer Companies, Inc. | Stable emulsions useful for skin care wipes |
| US20020192407A1 (en) * | 2001-03-01 | 2002-12-19 | The Procter & Gamble Company | Pre-moistened wipe with improved feel and softness |
| US20030059459A1 (en) * | 2001-09-14 | 2003-03-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Method of treating hair with heat and a cap which provides a signal regarding treatment |
| US6692637B2 (en) * | 2001-11-07 | 2004-02-17 | Tetra Holding (Us), Inc. | Dual density filter cartridge |
| DE10205193A1 (de) * | 2002-02-08 | 2003-08-21 | Beiersdorf Ag | Diolhaltige Reinigungszubereitungen |
| US7115551B2 (en) * | 2002-06-07 | 2006-10-03 | The Procter & Gamble Company | Cleansing articles for skin or hair |
| US20030228352A1 (en) * | 2002-06-07 | 2003-12-11 | The Procter & Gamble Company | Cleansing articles for skin or hair |
| US20050025817A1 (en) * | 2003-07-03 | 2005-02-03 | Bhatia Kuljit S. | Delivery system for topical medications |
| US7776355B2 (en) * | 2003-07-03 | 2010-08-17 | Medics Pharmaceutical Corporation | Delivery system for topical medications |
| US20050202068A1 (en) | 2004-03-12 | 2005-09-15 | Hasenoehrl Erik J. | Disposable nonwoven mitt |
| US7479289B2 (en) * | 2004-07-02 | 2009-01-20 | Medicis Pharmaceutical Corporation | Stable cleanser compositions containing sulfur |
| US7655682B2 (en) * | 2004-07-02 | 2010-02-02 | Medicis Pharmaceutical Corporation | Triple anti-irritant composition |
| EP1809139A2 (en) * | 2004-11-12 | 2007-07-25 | The Procter and Gamble Company | Treatment articles capable of conforming to an underlying shape |
| EP1910271A4 (en) * | 2005-07-01 | 2008-11-19 | Playtex Products Inc | AUTOBRONIZING SUBSTRATE |
| EP2010128A1 (en) * | 2006-04-07 | 2009-01-07 | Reckitt Benckiser Healthcare (UK) Limited | Personal care article |
| WO2007120606A2 (en) * | 2006-04-10 | 2007-10-25 | President And Fellows Of Harvard College | Methods for modulating formation and progression of cellulite |
| US20080041319A1 (en) | 2006-04-25 | 2008-02-21 | The Iams Company | Disposable wet nonwoven implement |
| EP2046177B1 (en) * | 2006-07-31 | 2016-11-30 | The Procter and Gamble Company | Cleansing articles for skin or hair |
| US20090105196A1 (en) * | 2007-06-22 | 2009-04-23 | Belinda Tsao Nivaggioli | Use of creatine compounds to treat dermatitis |
| US20090123389A1 (en) * | 2007-08-15 | 2009-05-14 | Malcolm Whitman | Methods for modulating Th17 cell development in the treatment and prevention of cellulite |
| WO2009023267A2 (en) * | 2007-08-15 | 2009-02-19 | President And Fellows Of Harvard College | Methods for modulating development and expansion of il-17 expressing cells |
| CN102177152A (zh) | 2008-08-11 | 2011-09-07 | 哈佛大学校长及研究员协会 | 用于抑制tRNA合成酶的卤夫酮(halofuginone)类似物和其用途 |
| US8262907B1 (en) | 2010-01-27 | 2012-09-11 | Central Garden And Pet Company | Composite sock filter for aquariums |
| CN101953654A (zh) * | 2010-04-19 | 2011-01-26 | 铜陵洁雅生物科技股份有限公司 | 消毒清洁湿巾及其制备方法 |
| WO2012153336A2 (en) | 2011-05-12 | 2012-11-15 | Rakuto Bio Technologies Ltd. | Methods and device for lightening skin complexion |
| JP2015506363A (ja) | 2012-01-13 | 2015-03-02 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ハロフジノール誘導体、および化粧料組成物および医薬組成物におけるその使用 |
| KR20150119468A (ko) | 2013-02-28 | 2015-10-23 | 더미라, 인코포레이티드 | 글리코피롤레이트 염 |
| US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
| US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
| US11118290B2 (en) | 2014-08-07 | 2021-09-14 | Gpcp Ip Holdings Llc | Structured, dispersible nonwoven web comprised of hydroentangled individualized bast fibers |
| EA201791051A1 (ru) | 2014-11-14 | 2018-01-31 | Мелинта Терапьютикс, Инк. | Способ лечения, профилактики или снижения риска возникновения кожной инфекции |
| US20170333400A1 (en) | 2016-05-17 | 2017-11-23 | Melinta Therapeutics, Inc. | Topical formulations of biaryl heterocyclic compounds and methods of use thereof |
| WO2019087124A1 (en) * | 2017-11-01 | 2019-05-09 | Clexio Biosciences Ltd. | Finished fibrous structures and methods of their use and preparation |
| WO2019237125A1 (en) | 2018-06-08 | 2019-12-12 | The General Hospital Corporation | Inhibitors of prolyl-trna-synthetase |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US28957A (en) * | 1860-07-03 | Steam-engine | ||
| US3550593A (en) * | 1967-02-02 | 1970-12-29 | Jack W Kaufman | Therapeutic apparatus |
| US3706595A (en) * | 1971-01-22 | 1972-12-19 | Johnson & Johnson | Method of applying a resin binder to a substrate |
| US3778341A (en) * | 1971-03-17 | 1973-12-11 | Johnson & Johnson | Nonwoven textile fabrics and methods of making the same |
| USRE28957E (en) | 1972-06-07 | 1976-09-07 | Johnson & Johnson | Synthetic resin compositions and methods of utilizing the same |
| JPS50150649A (ko) * | 1974-05-25 | 1975-12-03 | ||
| JPS5579316A (en) * | 1978-12-13 | 1980-06-14 | Nippon Ratetsukusu Kako Kk | Toilet napkin |
| US4341213A (en) * | 1981-08-13 | 1982-07-27 | The Kendall Co. | Bonded nonwoven fabrics |
| US4514385A (en) * | 1981-10-05 | 1985-04-30 | Alcon Laboratories, Inc. | Anti-acne compositions |
| DE3271930D1 (en) * | 1982-05-03 | 1986-08-14 | Richardson Vicks Ltd | Pharmaceutical preparation for the topical treatment of acne |
| EP0156080B2 (en) * | 1984-03-05 | 1993-10-20 | Nitto Denko Corporation | Percutaneous absorption type adhesive pharmaceutical preparation |
| JPS61280426A (ja) * | 1985-06-04 | 1986-12-11 | Ikeda Mohandou:Kk | 消炎鎮痛用貼付剤 |
| US4769022A (en) * | 1986-05-02 | 1988-09-06 | Minnesota Mining And Manufacturing Company | Cleansing pad |
| US4830854A (en) * | 1987-12-18 | 1989-05-16 | James B. Copelan | Chemical splinter removal |
| WO1989010738A1 (en) * | 1988-05-09 | 1989-11-16 | Solarcare, Inc. | Sunscreen composition and applicator system |
-
1988
- 1988-02-02 US US07/151,338 patent/US4891228A/en not_active Expired - Lifetime
-
1989
- 1989-01-27 MY MYPI89000103A patent/MY105806A/en unknown
- 1989-01-30 PH PH38120A patent/PH25977A/en unknown
- 1989-02-01 CA CA000589784A patent/CA1337897C/en not_active Expired - Fee Related
- 1989-02-01 EP EP89300950A patent/EP0327326B1/en not_active Expired - Lifetime
- 1989-02-01 AT AT89300950T patent/ATE89998T1/de active
- 1989-02-01 ES ES198989300950T patent/ES2040994T3/es not_active Expired - Lifetime
- 1989-02-01 DE DE89300950T patent/DE68906804T2/de not_active Expired - Fee Related
- 1989-02-01 KR KR1019890001141A patent/KR0136273B1/ko not_active IP Right Cessation
- 1989-02-01 NZ NZ227823A patent/NZ227823A/en unknown
- 1989-02-01 IE IE32189A patent/IE62870B1/en not_active IP Right Cessation
- 1989-02-01 AU AU29523/89A patent/AU613295B2/en not_active Ceased
- 1989-02-02 MX MX014754A patent/MX165382B/es unknown
- 1989-02-02 DK DK047789A patent/DK47789A/da not_active Application Discontinuation
- 1989-02-02 JP JP1024738A patent/JP2885815B2/ja not_active Expired - Lifetime
-
1993
- 1993-06-03 GR GR920403263T patent/GR3008079T3/el unknown
-
1998
- 1998-06-01 HK HK98104734A patent/HK1006146A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2952389A (en) | 1989-08-03 |
| JP2885815B2 (ja) | 1999-04-26 |
| MY105806A (en) | 1995-01-30 |
| DE68906804D1 (de) | 1993-07-08 |
| HK1006146A1 (en) | 1999-02-12 |
| IE62870B1 (en) | 1995-03-08 |
| DK47789D0 (da) | 1989-02-02 |
| ES2040994T3 (es) | 1993-11-01 |
| EP0327326A1 (en) | 1989-08-09 |
| MX165382B (es) | 1992-11-06 |
| US4891228A (en) | 1990-01-02 |
| DE68906804T2 (de) | 1993-11-18 |
| DK47789A (da) | 1989-08-03 |
| KR890012656A (ko) | 1989-09-18 |
| GR3008079T3 (ko) | 1993-09-30 |
| KR0136273B1 (ko) | 1998-04-25 |
| ATE89998T1 (de) | 1993-06-15 |
| JPH021408A (ja) | 1990-01-05 |
| NZ227823A (en) | 1991-06-25 |
| CA1337897C (en) | 1996-01-09 |
| AU613295B2 (en) | 1991-07-25 |
| EP0327326B1 (en) | 1993-06-02 |
| IE890321L (en) | 1989-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH25977A (en) | Medicated cleansing pads | |
| EP0327327B1 (en) | Medicated cleansing pads | |
| EP0652988B1 (en) | Laminated dual textured treatment pads | |
| EP0735866B1 (en) | Antimicrobial wipe compositions | |
| JP3848258B2 (ja) | 拭き取り型クレンジング製品及びその製造方法 | |
| DE3409079A1 (de) | Medizinische pflaster | |
| CA2564107A1 (en) | Exothermic cleansing article | |
| US6296869B1 (en) | Adhesive cosmetic patch containing alpha or beta hydroxy acids | |
| GB2222526A (en) | Cleansing pack | |
| WO2002078666A1 (en) | Metronidazole pledgets | |
| JPH09268122A (ja) | 貼付剤組成物 | |
| MXPA97003394A (en) | Wipes for cleaning treated with emulsion of water in lipi |